(Q37877279)

24 August 2017

1 reference

title

Guideline on the investigation, management and prevention of venous thrombosis in children (English)

1 reference

British Committee for Standards in Haematology

24 August 2017

0 references

8

object named as

British Committee for Standards in Haematology

1 reference

24 August 2017

Elizabeth Chalmers

1

1 reference

24 August 2017

Vijeya Ganesen

2

1 reference

24 August 2017

Ri Liesner

3

1 reference

24 August 2017

Sanjay Maroo

4

1 reference

24 August 2017

Timothy Nokes

5

1 reference

24 August 2017

D Saunders

6

1 reference

24 August 2017

Michael Williams

7

1 reference

24 August 2017

language of work or name

English

0 references

publication date

20 May 2011

1 reference

British Journal of Haematology

24 August 2017

1 reference

24 August 2017

154

1 reference

24 August 2017

2

1 reference

24 August 2017

196-207

1 reference

Grading quality of evidence and strength of recommendations

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Guidelines on oral anticoagulation (warfarin): third edition--2005 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Guidelines on use of vena cava filters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Clinical guidelines for testing for heritable thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Recanalisation of cerebral venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Safety and efficacy of danaparoid (Orgaran) use in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Epidemiology of venous thromboembolism in neonates and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Venous thrombosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Thrombolysis for cerebral vein and dural sinus thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Cerebral sinovenous thrombosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

The use of low molecular weight heparin in pediatric patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Going from evidence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Serial repositioning of a Günther tulip retrievable inferior vena cava filter in a pediatric patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Thrombosis during infancy and childhood: what we know and what we do not know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Noninvasive Diagnosis of Deep Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

High plasma levels of factor VIII and risk of recurrence of venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

How I treat venous thrombosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Warfarin therapy in children who require long-term total parenteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Cerebral venography: comparison of CT and MR projection venography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

D-dimer testing to determine the duration of anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Low-molecular-weight heparin in thrombotic disease in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Testing children for inherited thrombophilia: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Fibrin sheaths and central venous catheter occlusions: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Magnetic resonance venography in assessing venous patency after multiple venous catheters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Anticoagulation for cerebral sinus thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Cerebral venous thrombosis: correlation between recanalization and clinical outcome--a long-term follow-up of 40 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

MRI of Clot in Cerebral Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08543.X

10.1111/J.1365-2141.2010.08543.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference